Drug Profile
Research programme: anticancer therapeutics - 2cureX
Latest Information Update: 12 Jul 2016
Price :
$50
*
At a glance
- Originator 2cureX
- Class Antineoplastics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 12 Jul 2016 No recent reports on development identified - Preclinical for Colorectal cancer in Denmark (unspecified route)